no code implementations • 11 Oct 2023 • Kshitij Ingale, Sun Hae Hong, Josh S. K. Bell, Abbas Rizvi, Amy Welch, Lingdao Sha, Irvin Ho, Kunal Nagpal, Aicha Bentaieb, Rohan P Joshi, Martin C Stumpe
MET protein overexpression is a targetable event in non-small cell lung cancer (NSCLC) and is the subject of active drug development.
no code implementations • 18 Mar 2022 • Rohan P. Joshi, Bolesław L. Osinski, Niha Beig, Lingdao Sha, Kshitij Ingale, Martin C. Stumpe
The association of individual cell features with MET alterations suggested a predictive model could distinguish MET wild-type from MET amplification or MET exon 14 deletion.